Search Results

Filter
  • 1-10 of  550 results for ""Intracellular Signaling Peptides and Proteins genetics""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy.

  • Authors : Saalfeld FC; Clinic for Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; National Center for Tumor Diseases, Dresden, Germany

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics

  • Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Dec; Vol. 213, pp. 115065. Date of Electronic Publication: 2024 Oct 12.Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

NPHS Mutations in Pediatric Patients with Congenital and Steroid-Resistant Nephrotic Syndrome.

  • Authors : Lee JX; Department of Pediatrics, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia.; Tan YJ

Subjects: Nephrotic Syndrome*/Nephrotic Syndrome*/Nephrotic Syndrome*/genetics ; Nephrotic Syndrome*/Nephrotic Syndrome*/Nephrotic Syndrome*/congenital ; Nephrotic Syndrome*/Nephrotic Syndrome*/Nephrotic Syndrome*/drug therapy Nephrosis, congenital; Nephrotic syndrome, idiopathic, steroid-resistant

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Nov 15; Vol. 25 (22). Date of Electronic Publication: 2024 Nov 15.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Editorial & Opinion

Null-type SH2B3 mutations are potential drivers in a subset of Ph-negative myeloproliferative neoplasms.

  • Authors : Zhang X; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.; Ding Y

Subjects: Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/genetics ; Mutation* ; Adaptor Proteins, Signal Transducing*/Adaptor Proteins, Signal Transducing*/Adaptor Proteins, Signal Transducing*/genetics

  • Source: American journal of hematology [Am J Hematol] 2024 Sep; Vol. 99 (9), pp. 1841-1844. Date of Electronic Publication: 2024 Jun 25.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Primary pulmonary epithelioid hemangioendothelioma metastatic to the pleura and mediastinal lymph node with a prominent rhabdoid cytomorphology showing CAMTA1::WWTR1 fusion and novel PRDM1 and TNFRSF14 mutations.

  • Authors : Gonzalez MF; Department of Pathology and Laboratory Medicine, Temple University Hospital and Lewis Katz School of Medicine, Philadelphia, Pennsylvania, USA.; Seth A

Subjects: Hemangioendothelioma, Epithelioid*/Hemangioendothelioma, Epithelioid*/Hemangioendothelioma, Epithelioid*/genetics ; Hemangioendothelioma, Epithelioid*/Hemangioendothelioma, Epithelioid*/Hemangioendothelioma, Epithelioid*/pathology ; Hemangioendothelioma, Epithelioid*/Hemangioendothelioma, Epithelioid*/Hemangioendothelioma, Epithelioid*/diagnosis

  • Source: Cytopathology : official journal of the British Society for Clinical Cytology [Cytopathology] 2024 Sep; Vol. 35 (5), pp. 654-657. Date of Electronic Publication: 2024 Jun 28.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 9010345 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

NUP98::NSD1 and FLT3/ITD co-expression is an independent predictor of poor prognosis in pediatric AML patients.

  • Authors : Wang JW; Department of Pediatrics, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun Yat-Sen University, Guangzhou, China.

Subjects: fms-Like Tyrosine Kinase 3*/fms-Like Tyrosine Kinase 3*/fms-Like Tyrosine Kinase 3*/genetics ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/genetics ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/mortality

  • Source: BMC pediatrics [BMC Pediatr] 2024 Aug 24; Vol. 24 (1), pp. 547. Date of Electronic Publication: 2024 Aug 24.Publisher: BioMed Central Country of Publication: England NLM ID: 100967804 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2431

Record details

×
Academic Journal

A series of four patients with Sotos syndrome harboring novel NSD1 mutations: clinical and molecular description.

  • Authors : Amllal N; Research Team in Genomics and Molecular Epidemiology of Genetic Diseases, Genopath Centre, Faculty of Medicine and Pharmacy of Rabat, University Mohammed V of Rabat, Rabat, Morocco. .; Department of Medical Genetics, National Institute of Health, Rabat, Morocco. .

Subjects: Histone-Lysine N-Methyltransferase*/Histone-Lysine N-Methyltransferase*/Histone-Lysine N-Methyltransferase*/genetics ; Sotos Syndrome*/Sotos Syndrome*/Sotos Syndrome*/genetics ; Mutation*/Mutation*/Mutation*/genetics

  • Source: Molecular biology reports [Mol Biol Rep] 2024 Aug 03; Vol. 51 (1), pp. 885. Date of Electronic Publication: 2024 Aug 03.Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-4978

Record details

×
Academic Journal

[Genetic Variation of SH2B3 in Patients with Myeloid Neoplasms].

  • Authors : Ma Q; Department of Hematology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.; Hu RH

Subjects: Adaptor Proteins, Signal Transducing*/Adaptor Proteins, Signal Transducing*/Adaptor Proteins, Signal Transducing*/genetics ; Mutation* ; Intracellular Signaling Peptides and Proteins*/Intracellular Signaling Peptides and Proteins*/Intracellular Signaling Peptides and Proteins*/genetics

  • Source: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2024 Aug; Vol. 32 (4), pp. 1186-1190.Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

LNK/ SH2B3 as a novel driver in juvenile myelomonocytic leukemia.

  • Authors : Wintering A; Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158.; Hecht A

Subjects: Leukemia, Myelomonocytic, Juvenile*/Leukemia, Myelomonocytic, Juvenile*/Leukemia, Myelomonocytic, Juvenile*/genetics ; Leukemia, Myelomonocytic, Juvenile*/Leukemia, Myelomonocytic, Juvenile*/Leukemia, Myelomonocytic, Juvenile*/metabolism ; Leukemia, Myelomonocytic, Juvenile*/Leukemia, Myelomonocytic, Juvenile*/Leukemia, Myelomonocytic, Juvenile*/pathology

  • Source: Haematologica [Haematologica] 2024 Aug 01; Vol. 109 (8), pp. 2533-2541. Date of Electronic Publication: 2024 Aug 01.Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

NLRP12-associated autoinflammatory disease: A novel causal mutation and bioinformatics analyses.

  • Authors : Li Z; School of Biopharmacy, China Pharmaceutical University, Nanjing 211198, PR China; School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, PR China.

Subjects: Computational Biology*/Computational Biology*/Computational Biology*/methods ; Hereditary Autoinflammatory Diseases*/Hereditary Autoinflammatory Diseases*/Hereditary Autoinflammatory Diseases*/genetics ; Mutation*

  • Source: Clinical immunology (Orlando, Fla.) [Clin Immunol] 2024 Aug; Vol. 265, pp. 110278. Date of Electronic Publication: 2024 Jun 13.Publisher: Academic Press Country of Publication: United States NLM ID: 100883537 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

SH2B3 alterations in a novel genetic condition, juvenile myelomonocytic leukemia, and myeloproliferative neoplasia.

  • Authors : Niemeyer CM; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg. .; Erlacher M

Subjects: Leukemia, Myelomonocytic, Juvenile*/Leukemia, Myelomonocytic, Juvenile*/Leukemia, Myelomonocytic, Juvenile*/genetics ; Leukemia, Myelomonocytic, Juvenile*/Leukemia, Myelomonocytic, Juvenile*/Leukemia, Myelomonocytic, Juvenile*/diagnosis ; Leukemia, Myelomonocytic, Juvenile*/Leukemia, Myelomonocytic, Juvenile*/Leukemia, Myelomonocytic, Juvenile*/pathology

  • Source: Haematologica [Haematologica] 2024 Aug 01; Vol. 109 (8), pp. 2391-2394. Date of Electronic Publication: 2024 Aug 01.Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  550 results for ""Intracellular Signaling Peptides and Proteins genetics""